247 related articles for article (PubMed ID: 20200448)
21. Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation.
Michels AW; Ostrov DA; Zhang L; Nakayama M; Fuse M; McDaniel K; Roep BO; Gottlieb PA; Atkinson MA; Eisenbarth GS
J Immunol; 2011 Dec; 187(11):5921-30. PubMed ID: 22043012
[TBL] [Abstract][Full Text] [Related]
22. Unique features in the presentation of insulin epitopes in autoimmune diabetes: an update.
Wan X; Unanue ER
Curr Opin Immunol; 2017 Jun; 46():30-37. PubMed ID: 28456018
[TBL] [Abstract][Full Text] [Related]
23. Targeted delivery of antigen to intestinal dendritic cells induces oral tolerance and prevents autoimmune diabetes in NOD mice.
Chen Y; Wu J; Wang J; Zhang W; Xu B; Xu X; Zong L
Diabetologia; 2018 Jun; 61(6):1384-1396. PubMed ID: 29546475
[TBL] [Abstract][Full Text] [Related]
24. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans.
Serreze DV; Niens M; Kulik J; DiLorenzo TP
Methods Mol Biol; 2016; 1438():137-51. PubMed ID: 27150089
[TBL] [Abstract][Full Text] [Related]
25. Relative resistance to nasally induced tolerance in non-obese diabetic mice but not other I-A(g7)-expressing mouse strains.
Quinn A; Melo M; Ethell D; Sercarz EE
Int Immunol; 2001 Oct; 13(10):1321-33. PubMed ID: 11581177
[TBL] [Abstract][Full Text] [Related]
26. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
[TBL] [Abstract][Full Text] [Related]
27. A new look at MHC and autoimmune disease.
Ridgway WM; Fassò M; Fathman CG
Science; 1999 Apr; 284(5415):749, 751. PubMed ID: 10336398
[No Abstract] [Full Text] [Related]
28. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
29. NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells.
Birk OS; Elias D; Weiss AS; Rosen A; van-der Zee R; Walker MD; Cohen IR
J Autoimmun; 1996 Apr; 9(2):159-66. PubMed ID: 8738959
[TBL] [Abstract][Full Text] [Related]
30. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
[TBL] [Abstract][Full Text] [Related]
31. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.
Carrasco-Marin E; Shimizu J; Kanagawa O; Unanue ER
J Immunol; 1996 Jan; 156(2):450-8. PubMed ID: 8543793
[TBL] [Abstract][Full Text] [Related]
32. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors.
Silveira PA; Johnson E; Chapman HD; Bui T; Tisch RM; Serreze DV
Eur J Immunol; 2002 Dec; 32(12):3657-66. PubMed ID: 12516557
[TBL] [Abstract][Full Text] [Related]
33. Mouse pancreatic beta cells express MHC class II and stimulate CD4(+) T cells to proliferate.
Zhao Y; Scott NA; Quah HS; Krishnamurthy B; Bond F; Loudovaris T; Mannering SI; Kay TW; Thomas HE
Eur J Immunol; 2015 Sep; 45(9):2494-503. PubMed ID: 25959978
[TBL] [Abstract][Full Text] [Related]
34. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance.
Denzin LK
Front Immunol; 2013 Dec; 4():465. PubMed ID: 24381574
[TBL] [Abstract][Full Text] [Related]
36. Revisiting nonclassical HLA II functions in antigen presentation: Peptide editing and its modulation.
Álvaro-Benito M; Freund C
HLA; 2020 Oct; 96(4):415-429. PubMed ID: 32767512
[TBL] [Abstract][Full Text] [Related]
37. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
[TBL] [Abstract][Full Text] [Related]
38. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM.
Peterson M; Sant AJ
J Immunol; 1998 Sep; 161(6):2961-7. PubMed ID: 9743359
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes.
Kawamoto K; Pahuja A; Nettles A; Honkanen-Scott M; Bansal-Pakala P
Autoimmunity; 2012 Jun; 45(4):310-9. PubMed ID: 22390157
[TBL] [Abstract][Full Text] [Related]
40. The MHC Class II Antigen-Processing and Presentation Pathway Is Dysregulated in Type 1 Diabetes.
Gilles A; Hu L; Virdis F; Sant'Angelo DB; Dimitrova N; Hedrick JA; Denzin LK
J Immunol; 2023 Dec; 211(11):1630-1642. PubMed ID: 37811896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
